Ofatumumab versus rituximab salvage chemoimmunotherapy in relapsed or refractory diffuse large B-cell lymphoma: The ORCHARRD study.
Journal of Clinical Oncology.
Times cited: 4
- Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study. Nutrition Reviews. 2017 Academic Article GET IT
Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: Final results from a pivotal study.
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting.
Times cited: 12